These observations validate amiR-mediated silencing of two fundamental AR co-regulators in human cells, suggesting a potential translation of this strategy to SBMA patients and possibly other AR-associated GOF diseases, such as prostate cancer and cancer types with a sex bias. This evidence concerns the gene AR and prostate carcinoma.